NEOGENOMICS INC — Director's Dealing 2012

Feb 16, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NGNM.OB)
CIK: 0001077183
Period of Report: 2012-02-15

Reporting Person: VAN OORT DOUGLAS M (Director, Chairman and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-02-14	Stock options ( Right to Buy)	$1.71	A	800000	Acquired	2017-02-14	Common Stock (0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	803956	Indirect
Common Stock	8600	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock options ( Right to Buy)	$0.8	2016-03-15	Common Stock (0)	1000000	Direct
Warrants (Right to Buy)	$1.05	2014-03-15	Common Stock (0)	625000	Direct

Footnotes

F1: On February 14, 2012 Mr. VanOort was granted options to purchase 800,000 shares. There shares vest equally over each of the first four anniversaries of the grant date.

F2: On March 15, 2009 Mr. VanOort was granted options to purchase 1,000,000 shares. The grant was comprised of 500,000 time based options and 500,000 peformance based options. The first date that vesting became available was December 31, 2009.

F3: On March 16, 2009 Mr. VanOort was granted a warrant to purchase 625,000 shares. Of this total 125,000 warrants wer immediately exercisable and vested. The remaining 500,000 of warrants vest based on the performance of the Company's stock price and are not exercisable or vested at the present time.